Lv1
80 积分 2023-03-30 加入
Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma
2个月前
已完结
Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma
2个月前
已完结
Safety evaluation of ceftazidime/avibactam based on FAERS database
6个月前
已完结